AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 29 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $8,194,000 | -69.5% | 7,500,000 | -60.5% | 0.01% | -74.1% |
| Q4 2016 | $26,904,000 | +58.3% | 19,000,000 | +26.7% | 0.03% | +58.8% |
| Q3 2016 | $17,000,000 | +53.4% | 15,000,000 | +50.0% | 0.02% | +41.7% |
| Q2 2016 | $11,081,000 | -21.7% | 10,000,000 | -23.1% | 0.01% | -33.3% |
| Q1 2016 | $14,143,000 | -35.9% | 13,000,000 | -25.7% | 0.02% | -25.0% |
| Q4 2015 | $22,081,000 | -45.2% | 17,500,000 | -30.0% | 0.02% | -36.8% |
| Q3 2015 | $40,299,000 | -46.5% | 25,000,000 | -14.2% | 0.04% | -41.5% |
| Q2 2015 | $75,377,000 | +41.5% | 29,125,000 | +13.7% | 0.06% | +30.0% |
| Q1 2015 | $53,272,000 | +35.0% | 25,625,000 | +8.5% | 0.05% | +28.2% |
| Q4 2014 | $39,462,000 | +68.4% | 23,625,000 | +35.0% | 0.04% | +56.0% |
| Q3 2014 | $23,439,000 | +33.6% | 17,500,000 | +6.1% | 0.02% | +25.0% |
| Q2 2014 | $17,544,000 | +4.5% | 16,500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2014 | $16,786,000 | – | 16,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 22,000,000 | $24,050,000 | 2.14% |
| LINDEN ADVISORS LP | 35,213,000 | $38,458,000 | 1.43% |
| Bruce & Co., Inc. | 5,500,000 | $5,775,000 | 1.38% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,003,000 | $12,059,000 | 1.23% |
| MACKAY SHIELDS LLC | 16,877,000 | $18,442,000 | 0.84% |
| ANGELO GORDON & CO., L.P. | 11,000,000 | $11,983,000 | 0.73% |
| IRON Financial LLC | 535,000 | $585,000 | 0.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,111,000 | 0.31% |
| Sonora Investment Management, LLC | 1,430,000 | $1,556,598,000 | 0.30% |
| SSI INVESTMENT MANAGEMENT LLC | 2,830,000 | $3,084,000 | 0.28% |